Fletikumab (NNC0109-0012) (INN) is a monoclonal antibody designed for the treatment of rheumatoid arthritisStatement On A Nonproprietary Name Adopted By The USAN Council - Fletikumab, American Medical Association. that targets IL-20.
This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation.
References